Cost-effectiveness analysis of azacitidine in the treatment of high-risk myelodysplastic syndromes in Spain

BACKGROUND: The objective of the study was to analyse whether azacitidine is a cost-effective option for the treatment of myelodysplastic syndrome in the Spanish setting compared with conventional care regimens, including best supportive care, low dose chemotherapy and standard dose chemotherapy. ME...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Crespo, Carlos, Moreno, Estela, Sierra, Jordi, Serip, Suzan, Rubio, Marta
Format: Artigo
Jezik:Inglês
Izdano: Springer 2013
Teme:
Research
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC4029489/
https://ncbi.nlm.nih.gov/pubmed/24314138
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2191-1991-3-28
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki